Dr. Orlowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2406 Century Pl Se
Hickory, NC 28602Phone+1 828-324-9550Fax+1 828-324-4154- Is this information wrong?
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1981 - 1983
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1981- Washington University in St. Louis School of MedicineClass of 1978
Certifications & Licensure
NC State Medical License 1982 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 38 citationsBone Marker–Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK StudyNoopur Raje, Robert Vescio, Charles W. Montgomery, Ashraf Badros, Nikhil C. Munshi, Richard Orlowski, Joseph T. Hadala, Ghulam Warsi, Eliza Argonza-Aviles, Solveig G. ...> ;Clinical Cancer Research. 2016 Mar 15
Professional Memberships
- Member
Hospital Affiliations
Caldwell UNC Health CareLenoir, North Carolina
Catawba Valley Medical CenterHickory, North Carolina
Charles George Veterans Affairs Medical CenterAsheville, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
